Semifinalist Teams Selected in $10M ANA Avatar XPRIZE Competition
Tuesday, April 6, 2021 3:30PM IST (10:00AM GMT)
38 semifinalist teams from 16 countries will aim to create an avatar system that can transport human presence to a remote location instantly.
Los Angeles, United States:
XPRIZE, the world’s leader in designing and operating incentive competitions to solve humanity’s grand challenges, announced today that 38 teams from 16 countries are advancing to the semifinals round of the $10M ANA Avatar XPRIZE competition.
Sponsored by All Nippon Airways (ANA), Japan’s largest airline, the Avatar XPRIZE is a four-year global competition focused on the development of an avatar system that will deploy a human’s senses, actions, and presence to a remote location in real time, leading to a more connected world. These avatars must demonstrate the ability to execute tasks across a variety of real-world s
XPRIZE, one of the worldâs leader in designing and operating incentive competitions to solve humanityâs grand challenges, sponsored by nonprofit venture philanthropy organization New Profit and in partnership with JFF, March 8 announced 10 teams, including one team led by Indian Americans, to the Qualified Teams round of the competition.
Among the 10 teams from 4 countries advancing in the $5M XPRIZE Rapid Reskilling competition was Ramji Raghavan-led and Ajay Sharda-led Pragya Systems.
The Cambridge, Massachusetts-based Pragya was founded with a vision of significantly improving the quality and relevance of higher education while reducing its cost. Pragya has launched a new class of higher education technology focused on dramatically simplifying the flow of information on and off campuses for students, faculty, administrators, alumni and employers, the company site explains.
Grand Prize Winners Selected in $6M XPRIZE Rapid Covid Testing Competition to Create Fast, Frequent, Cheap, and Easy-to-Use Solutions
Dr. Rick Bright, Ph.D., Immunology and Molecular Pathogenesis
Shawna Butler, R.N. M.D.A., Nurse Economist
Dr. Charity Dean, CEO and Co-Founder, The Public Health Company
Dr. Paul Drain, Associate Professor, Departments of Global Health, Medicine and Epidemiology at the University of Washington
Dr. Anita Goel, Physicist and Physician, Chairman and CEO, Nanobiosym
Dr. Michael Mina, Physician-Scientist and Assistant Professor, Epidemiology and Immunology and Infectious Diseases at the Harvard School of Public Health
Dr. Anne Wyllie, Associate Research Scientist, Yale School of Public Health
qualified teams in the $5 million
XPRIZE Rapid Reskilling global competition.
Launched in June last year, the XPRIZE competition incentivises teams to develop and demonstrate the effectiveness of a quick training and reskilling solution for individuals most vulnerable to employment loss in the US. As we saw unemployment reach new heights and some jobs completely eliminated as automation accelerated during the pandemic, the XPRIZE Rapid Reskilling competition became
critical in providing pathways to gainful long-term employment, XPRIZE CEO Anousheh Ansari said in a statement.
Advertisement
There were 118 entries from 20 countries. The 10 qualified teams from 4 countries will now move to the Qualified Teams round of the competition.
(2)
Winning AI models from VALENCIA IA4COVID19 of Spain and JSI vs COVID of Slovenia will help support decision-makers in determining pandemic intervention policies to safely reopen society
XPRIZE, the world s leader in designing and operating incentive competitions to solve humanity s grand challenges, in partnership with
Cognizant
(Nasdaq: CTSH), one of the world s leading technology and professional services companies, today announced the Grand Prize Winners in the
$500K Pandemic Response Challenge. The four-month global competition was designed to harness the power of data and artificial intelligence in equipping policymakers, health officials and business leaders with the insights and guidance necessary to implement public safety measures that help keep local economies open while minimizing virus outbreaks as vaccines become more widely available. These decision-makers are encouraged to use the results, methodologies and technology from the challenge as reference on appro